CLINICAL_TRIALS
research
· 2015-02-06
Clinical Trial Update: Threat-Avoidance Learning in Anxiety Patients
Summary
KU Leuven reports a clinical trial update on threat-avoidance learning in anxiety patients, focusing on panic disorder, phobias, and PTSD; the current status is…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: KU Leuven | Conditions: Panic Disorder, Phobic Disorders | Status: UNKNOWN